The Moroccan Association of Interventional Pulmonology (AMPI) is set to organize its second international congress from June 4 to June 6, 2026. Under the auspices of the Lalla Salma Foundation, this landmark event aims to make significant strides in the fields of respiratory medicine and thoracic oncology.
This premier medical gathering will take place in the vibrant city of Marrakech, bringing together an impressive array of national and international experts, researchers, and healthcare professionals. Over the course of three days, participants will engage in discussions surrounding the latest medical advancements, technological innovations, and cutting-edge techniques for managing respiratory diseases and lung cancer.
Gathering of Global Experts
The congress promises to be a dynamic platform where top-tier medical professionals will convene to explore new approaches in thoracic oncology and interventional pulmonology. The clear objective for the organizers is to elevate Moroccan medicine to meet the highest international standards. The program is designed to be comprehensive, seamlessly blending high-level theoretical discussions with practical, hands-on experiences.
Engaging Sessions and Practical Immersion
One of the standout features of this congress is its educational balance, offering:
- Keynote Lectures: Led by world-renowned authorities in the field, these sessions will provide insights into the current state of the art and future medical revolutions.
- Immersive Workshops: Participants will have the chance to engage practically through simulation workshops and live demonstrations of advanced interventional techniques.
“These interactive sessions present a unique opportunity for our practitioners to enhance their skills, engage with the latest technological innovations, and interact directly with leading experts in the field,” emphasized representatives from AMPI.
Beyond serving as a scientific showcase, this congress embodies a long-term public health initiative. Through the work of AMPI, the Moroccan medical community is reaffirming its commitment to structuring national research, enhancing the continuing education of young physicians, and ultimately improving the quality of care provided to patients suffering from respiratory and thoracic diseases.
As respiratory diseases and thoracic cancers continue to pose significant public health challenges, interventional pulmonology is increasingly recognized as an essential therapeutic tool. This week, Marrakech will be the backdrop for shaping its promising future.
As reported by industries.ma.
